GOLDENWELL BIOTECH, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Goldenwell Biotech, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • Goldenwell Biotech, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $0.000.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $0 $0 Sep 30, 2024 10-Q 2024-11-26
Q2 2024 $0 $0 Jun 30, 2024 10-Q 2024-08-22
Q1 2024 $0 $0 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 $0 -$26.3K -100% Dec 31, 2023 10-Q 2024-11-26
Q3 2023 $0 -$31.1K -100% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $0 -$34.8K -100% Jun 30, 2023 10-Q 2023-08-17
Q1 2023 $0 -$42.3K -100% Mar 31, 2023 10-Q 2023-05-19
Q4 2022 $26.3K -$22.4K -46% Dec 31, 2022 10-K 2024-04-12
Q3 2022 $31.1K -$21.4K -40.7% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $34.8K -$23.2K -40% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $42.3K -$21.3K -33.4% Mar 31, 2022 10-Q 2022-05-18
Q4 2021 $48.8K +$48.8K Dec 31, 2021 10-K 2023-04-13
Q3 2021 $52.4K Sep 30, 2021 10-Q 2022-01-03
Q2 2021 $58K Jun 30, 2021 10-Q 2021-12-02
Q1 2021 $63.6K Mar 31, 2021 10-Q 2021-08-05
Q4 2020 $0 Dec 31, 2020 10-K/A 2023-02-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.